Background & Sources: Scientific review of Xeljanz and Blood Clots risk

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Scientific review of Xeljanz and Blood Clots risk — Research Summary — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.